Meng Cheng

Oxytocin Nanogels Inhibit Innate Inflammatory Response for Early Intervention in Alzheimer's Disease.

Junping Wang, Yan Dou, Zuhao Sun, 2022, ACS applied materials & interfaces.

Engineered macrophage-biomimetic versatile nanoantidotes for inflammation-targeted therapy against Alzheimer's disease by neurotoxin neutralization and immune recognition suppression

Yuyang Miao, Haonan Li, Junping Wang, 2023, Bioactive materials.

Abnormal Regional Spontaneous Brain Activities in White Matter in Patients with Autism Spectrum Disorder

Kaizhong Xue, Dan Zhu, Lin Ma, 2022, Neuroscience.

mTOR-Mediated Immunometabolic Reprogramming Nanomodulators Enable Sensitive Switching of Energy Deprivation-Induced Microglial Polarization for Alzheimer's Disease Management.

Yining Liu, Yan Dou, Dongjun Zhao, 2023, ACS nano.

Carrier-free quercetin nanomedicine blocks NLRP3 deubiquitination and TXNIP recruitment for Parkinson’s disease therapy

Yining Liu, Gaoju Pang, Yan Dou, 2023, Chemical Engineering Journal.

Female-sensitive multifunctional phytoestrogen nanotherapeutics for tailored management of postmenopausal Alzheimer's disease

Yan Dou, Fan Yang, Meng Cheng, 2024, Nano Today.

Cross-scale targeted remodeling of neurovascular and neurometabolic coupling in Alzheimer’s disease by natural self-assembled SIRT1 activator

Yan Dou, Fan Yang, Meng Cheng, 2024, Nano Today.